Publication | Open Access

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis

OncologyIntensive Two-drug ChemotherapyMedicineFour-drug VsClinical TrialsBronchial NeoplasmPharmacotherapyPoor PrognosisCancer TreatmentPharmacologyCancer ChemotherapyLung Cancer